Research Article

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

See allHide authors and affiliations

Science  03 Sep 2010:
Vol. 329, Issue 5996, pp. 1168-1174
DOI: 10.1126/science.1193748

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

  • Effect on Risk Compensation

    Q. A. Karim et al. have at last produced evidence of a vaginal microbicide that is more effective than placebo in preventing HIV-1 infection in women ("Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women," Research Articles, 3 September 2010, p. 1168; Published online 19 July 2010). However, they state in the discussion that "Encouragingly, there was no...

    Show More
    Competing Interests: None declared.

Navigate This Article